C-reactive protein: a story half told.
C-reactive protein: a story half told.
复制标题
C反应蛋白:故事讲了一半。
DOI:
10.1046/j.1525-139x.2000.00038.x
复制
发表时间:
2000
影响因子:
1.6
通讯作者:
Kaysen,GA
中科院分区:
文献类型:
--
作者:
Kaysen,GA
Mortality of patients with end-stage renal disease (ESRD) remains a significant problem, with the rate of death similar to that of many metastatic malignancies (1). One of the most powerful predictors of mortality in cross-sectional studies is a low serum albumin (2). This has been interpreted as indicating the presence of malnutrition, possibly resulting from anorexia arising in part from inadequate dialysis. Much attention has been focused on improving dietary intake through counseling, dietary supplements, and intradialytic parenteral nutrition. Much money and time have been spent on these efforts but the benefits have not been impressive. There are a number of reasons for the disappointing effects of nutritional intervention on what has been assumed to be a nutritional lesion. The major one probably arises from the fact that much of the cause of hypoalbuminemia and of malnutrition is the consequence of inflammation.Albumin, like other “nutritional markers” such as prealbumin (transthyretin)(3–6) and transferrin (7), is a negative acute phase protein (8). The synthesis of these proteins decreases during inflammation, as does their serum concentration, changes that occur entirely independently of nutritional state (8). Albumin concentration in dialysis patients is negatively correlated with levels of positive acute phase proteins. These are proteins whose synthesis and serum concentration increase during inflammation [C-reactive protein (CRP), serum amyloid A (SAA)(9, 10), fibrinogen, ferritin], an increase that is regulated by and results from an increase in the cytokines [interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α)](11, 12). These markers of inflammation are statistically powerful determinants of albumin level in ESRD patients.